Form 4: Gilead SVP Burkhart Granted 8,890 Restricted Stock Units

Gilead Sciences, Inc. SVP of Controllership, Erin Burkhart, was granted 8,890 restricted stock units with a four-year vesting schedule.

Summary

• Erin Burkhart, SVP, Controllership of Gilead Sciences, Inc. (GILD), acquired 8,890 Restricted Stock Units (RSUs).
• Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
• The RSUs have a 4-year vesting schedule, with 25% vesting on the first anniversary of the grant date (September 22, 2026) and the remaining balance vesting at 6.25% quarterly thereafter until fully vested.

Sentiment

Score: 7

Explanation: The filing reports a routine grant of equity compensation to a senior executive, which is positive for executive retention and alignment of interests, but does not indicate significant operational or financial news for the company.

Positives

• Erin Burkhart, SVP, Controllership, received a grant of 8,890 Restricted Stock Units, which aligns her interests with those of shareholders.

Future Outlook

No specific forward-looking statements or guidance are provided beyond the vesting schedule of the granted restricted stock units.

Industry Context

This filing reports a routine executive compensation event, which is a standard practice across various industries to incentivize and retain senior management by aligning their long-term interests with company performance.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon vesting and conversion of RSUs into common stock, balanced by increased alignment of executive interests with shareholder value.
• Employees: Reflects standard executive compensation practices within the company.

Next Steps

• The first 25% of the Restricted Stock Units will vest on September 22, 2026.
• The remaining balance of the Restricted Stock Units will vest quarterly at 6.25% until fully vested over a four-year period.

Key Dates

Keywords

Gilead Sciences, GILD, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4